Modulation of the Surgical Inflammatory Response by Etoricoxib
Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that orally administered etoricoxib
(COX-2) modulates prostaglandin and cytokine synthesis in the central nervous system (CNS)
and in the periphery in surgical patients and thus reduces pain and suffering.
Phase:
Phase 2
Details
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Collaborators:
HELIOS Kliniken GmbH Merck Sharp & Dohme Corp. Rush University Medical Center